Structured evidence table for Lutein Supplementation Visual Fatigue Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lutein Supplementation Visual Fatigue Randomized Trial | 7 9 The standard of care for many IRDs has largely focused on managing associated complications and the use of optical aids to improve quality of life. | 4 | Barthelemy Normila (2026) | Nutritional supplements: current evidence for retinitis pigmentosa and Stargardt disease |
| Lutein Supplementation Visual Fatigue Randomized Trial | This review synthesizes both historical and contemporary evidence regarding dietary and nutritional interventions for IRDs.  14 Retinitis pigmentosa is one of the most common IRDs and is characterized by progressive photoreceptor cell death. | 4 | Barthelemy Normila (2026) | Nutritional supplements: current evidence for retinitis pigmentosa and Stargardt disease |
| Lutein Supplementation Visual Fatigue Randomized Trial | By applying next-generation sequencing (NGS) technology to DNA samples stored from patients of the previous vitamin A trials, they were able to identify the specific RP gene variants for most participants and the lack of protective effect across genetic subtypes such as,and-associated retinitis pigmentosa []. | 4 | Barthelemy Normila (2026) | Nutritional supplements: current evidence for retinitis pigmentosa and Stargardt disease |
| Lutein Supplementation Visual Fatigue Randomized Trial | 1 4 5 6 Inherited retinal diseases (IRDs) comprise a complex group of heterogenous disorders that lead to progressive retinal cell death and functional vision loss. | 4 | Barthelemy Normila (2026) | Nutritional supplements: current evidence for retinitis pigmentosa and Stargardt disease |
Source documents